1. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
   Justin F. Creeden et al, 2020, International Journal of Molecular Sciences CrossRef
2. Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling
   Emily S. Humphrey et al, 2016, Molecular & Cellular Proteomics CrossRef
3. Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination
   Shelby Lennon et al, 2019, Clinical Cancer Research CrossRef
4. Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma
   Havish S. Kantheti et al, 2024, International Journal of Molecular Sciences CrossRef
5. Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions
   Constantinos Giaginis et al, 2016, Pathology & Oncology Research CrossRef
6. The Roles of EphB2 in Cancer
   Wei Liu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
7. EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System
   K.R. Kampen et al, 2015, Molecular Cancer Research CrossRef
8. Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion
   CHENGLI LIU et al, 2014, Oncology Letters CrossRef
9. Simultaneous targeting of Eph receptors in glioblastoma
   Sara Ferluga et al, 2016, Oncotarget CrossRef
10. The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment
    Oscar J Buckens et al, 2020, Expert Opinion on Investigational Drugs CrossRef
11. Ephb receptors and persistent pain
    Isabella Gavazzi, 2016, An Introduction to Pain and its Relation to Nervous System Disorders CrossRef
12. Eph receptors: New players in Alzheimer's disease pathogenesis
    Moustapha Cissé et al, 2015, Neurobiology of Disease CrossRef
13. Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
    James RW Conway et al, 2019, Gut CrossRef
14. The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
    Stavros P. Papadakos et al, 2023, International Journal of Molecular Sciences CrossRef
15. EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling
    Shinya Sato et al, 2019, JCI Insight CrossRef